Suzanne R. Burstein

Suzanne R. Burstein is a seasoned professional in the field of preclinical development with a strong background in neuroscience and neurodegenerative diseases. Currently serving as Senior Director of Preclinical at Neurogene Inc. since December 2020, Suzanne has advanced through various roles, including Director and Associate Director of Preclinical Development. Prior experience includes positions as a Scientist and Associate Scientist at Prevail Therapeutics, as well as a Postdoctoral Research Fellow at The New York Stem Cell Foundation Research Institute. Suzanne's academic background includes a PhD from Joan & Sanford I. Weill Medical College of Cornell University, where research focused on mitochondrial dysfunction in neurodegenerative disease. Additional educational credentials include a Bachelor of Science in Biology from Lehigh University.